ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea · Delayed Price · Currency is KRW 93,300
-2,300 (-2.41%)
Oct 2, 2026, 3:30 PM KST
ST Pharm Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, ST Pharm stock has a consensus rating of "Strong Buy" and an average price target of ₩177,778. The average 1-year stock price forecast is 90.54% higher than the current stock price, while the lowest is ₩140,000 (+50.05%) and the highest is ₩210,000 (+125.08%).
Price Target: ₩177,778 (+90.54%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ST Pharm stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 7 | 6 | 6 | 6 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 11 | 10 | 10 | 9 |
Financial Forecast
Revenue This Year
419.26B
from 331.68B
Increased by 26.40%
Revenue Next Year
510.67B
from 419.26B
Increased by 21.80%
EPS This Year
3.37K
from 2.69K
Increased by 25.37%
EPS Next Year
4.35K
from 3.37K
Increased by 29.01%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.